The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Interventional Oncology Ablation Market Research Report 2025
Synopsis
Tumor Ablation is a general term for destroying cancer cells. Interventional ablation is a targeted, image-guided therapy for liver, kidney and lung cancers that uses the direct application of extreme heat (radiofrequency and microwave) or cold (cryoablation) to destroy tumor cells. It is most appropriate for small kidney and liver cancers that cannot be removed surgically. In fact, radiofrequency and cryoablation of small kidney cancers have been shown to be just as effective as major surgery.
The global Interventional Oncology Ablation market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Interventional Oncology Ablation is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Interventional Oncology Ablation is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Interventional Oncology Ablation in Hospitals & Clinics is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Interventional Oncology Ablation include Boston Scientific Corporation, Johnson & Johnson, Medtronic Plc, Varian Medical Systems, Inc., EDAP TMS S.A., AngioDynamics, CASCINATION AG, Merit Medical Systems, Inc. and STARmed Co., etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Interventional Oncology Ablation, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Interventional Oncology Ablation.
Report Scope
The Interventional Oncology Ablation market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Interventional Oncology Ablation market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Interventional Oncology Ablation companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Boston Scientific Corporation
Johnson & Johnson
Medtronic Plc
Varian Medical Systems, Inc.
EDAP TMS S.A.
AngioDynamics
CASCINATION AG
Merit Medical Systems, Inc.
STARmed Co.
Biomedical Srl
Segment by Type
Radiofrequency Ablation
Microwave Ablation
Cryoablation
Irreversible Electroporation Ablation
Segment by Application
Hospitals & Clinics
Ambulatory Surgical Centers
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Interventional Oncology Ablation companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Tumor Ablation is a general term for destroying cancer cells. Interventional ablation is a targeted, image-guided therapy for liver, kidney and lung cancers that uses the direct application of extreme heat (radiofrequency and microwave) or cold (cryoablation) to destroy tumor cells. It is most appropriate for small kidney and liver cancers that cannot be removed surgically. In fact, radiofrequency and cryoablation of small kidney cancers have been shown to be just as effective as major surgery.
The global Interventional Oncology Ablation market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Interventional Oncology Ablation is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Interventional Oncology Ablation is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Interventional Oncology Ablation in Hospitals & Clinics is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Interventional Oncology Ablation include Boston Scientific Corporation, Johnson & Johnson, Medtronic Plc, Varian Medical Systems, Inc., EDAP TMS S.A., AngioDynamics, CASCINATION AG, Merit Medical Systems, Inc. and STARmed Co., etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Interventional Oncology Ablation, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Interventional Oncology Ablation.
Report Scope
The Interventional Oncology Ablation market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Interventional Oncology Ablation market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Interventional Oncology Ablation companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Boston Scientific Corporation
Johnson & Johnson
Medtronic Plc
Varian Medical Systems, Inc.
EDAP TMS S.A.
AngioDynamics
CASCINATION AG
Merit Medical Systems, Inc.
STARmed Co.
Biomedical Srl
Segment by Type
Radiofrequency Ablation
Microwave Ablation
Cryoablation
Irreversible Electroporation Ablation
Segment by Application
Hospitals & Clinics
Ambulatory Surgical Centers
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Interventional Oncology Ablation companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Interventional Oncology Ablation Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Radiofrequency Ablation
1.2.3 Microwave Ablation
1.2.4 Cryoablation
1.2.5 Irreversible Electroporation Ablation
1.3 Market by Application
1.3.1 Global Interventional Oncology Ablation Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals & Clinics
1.3.3 Ambulatory Surgical Centers
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Interventional Oncology Ablation Market Perspective (2019-2030)
2.2 Interventional Oncology Ablation Growth Trends by Region
2.2.1 Global Interventional Oncology Ablation Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Interventional Oncology Ablation Historic Market Size by Region (2019-2024)
2.2.3 Interventional Oncology Ablation Forecasted Market Size by Region (2025-2030)
2.3 Interventional Oncology Ablation Market Dynamics
2.3.1 Interventional Oncology Ablation Industry Trends
2.3.2 Interventional Oncology Ablation Market Drivers
2.3.3 Interventional Oncology Ablation Market Challenges
2.3.4 Interventional Oncology Ablation Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Interventional Oncology Ablation Players by Revenue
3.1.1 Global Top Interventional Oncology Ablation Players by Revenue (2019-2024)
3.1.2 Global Interventional Oncology Ablation Revenue Market Share by Players (2019-2024)
3.2 Global Interventional Oncology Ablation Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Interventional Oncology Ablation Revenue
3.4 Global Interventional Oncology Ablation Market Concentration Ratio
3.4.1 Global Interventional Oncology Ablation Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Interventional Oncology Ablation Revenue in 2023
3.5 Interventional Oncology Ablation Key Players Head office and Area Served
3.6 Key Players Interventional Oncology Ablation Product Solution and Service
3.7 Date of Enter into Interventional Oncology Ablation Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Interventional Oncology Ablation Breakdown Data by Type
4.1 Global Interventional Oncology Ablation Historic Market Size by Type (2019-2024)
4.2 Global Interventional Oncology Ablation Forecasted Market Size by Type (2025-2030)
5 Interventional Oncology Ablation Breakdown Data by Application
5.1 Global Interventional Oncology Ablation Historic Market Size by Application (2019-2024)
5.2 Global Interventional Oncology Ablation Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Interventional Oncology Ablation Market Size (2019-2030)
6.2 North America Interventional Oncology Ablation Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Interventional Oncology Ablation Market Size by Country (2019-2024)
6.4 North America Interventional Oncology Ablation Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Interventional Oncology Ablation Market Size (2019-2030)
7.2 Europe Interventional Oncology Ablation Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Interventional Oncology Ablation Market Size by Country (2019-2024)
7.4 Europe Interventional Oncology Ablation Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Interventional Oncology Ablation Market Size (2019-2030)
8.2 Asia-Pacific Interventional Oncology Ablation Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Interventional Oncology Ablation Market Size by Region (2019-2024)
8.4 Asia-Pacific Interventional Oncology Ablation Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Interventional Oncology Ablation Market Size (2019-2030)
9.2 Latin America Interventional Oncology Ablation Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Interventional Oncology Ablation Market Size by Country (2019-2024)
9.4 Latin America Interventional Oncology Ablation Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Interventional Oncology Ablation Market Size (2019-2030)
10.2 Middle East & Africa Interventional Oncology Ablation Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Interventional Oncology Ablation Market Size by Country (2019-2024)
10.4 Middle East & Africa Interventional Oncology Ablation Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Boston Scientific Corporation
11.1.1 Boston Scientific Corporation Company Detail
11.1.2 Boston Scientific Corporation Business Overview
11.1.3 Boston Scientific Corporation Interventional Oncology Ablation Introduction
11.1.4 Boston Scientific Corporation Revenue in Interventional Oncology Ablation Business (2019-2024)
11.1.5 Boston Scientific Corporation Recent Development
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Company Detail
11.2.2 Johnson & Johnson Business Overview
11.2.3 Johnson & Johnson Interventional Oncology Ablation Introduction
11.2.4 Johnson & Johnson Revenue in Interventional Oncology Ablation Business (2019-2024)
11.2.5 Johnson & Johnson Recent Development
11.3 Medtronic Plc
11.3.1 Medtronic Plc Company Detail
11.3.2 Medtronic Plc Business Overview
11.3.3 Medtronic Plc Interventional Oncology Ablation Introduction
11.3.4 Medtronic Plc Revenue in Interventional Oncology Ablation Business (2019-2024)
11.3.5 Medtronic Plc Recent Development
11.4 Varian Medical Systems, Inc.
11.4.1 Varian Medical Systems, Inc. Company Detail
11.4.2 Varian Medical Systems, Inc. Business Overview
11.4.3 Varian Medical Systems, Inc. Interventional Oncology Ablation Introduction
11.4.4 Varian Medical Systems, Inc. Revenue in Interventional Oncology Ablation Business (2019-2024)
11.4.5 Varian Medical Systems, Inc. Recent Development
11.5 EDAP TMS S.A.
11.5.1 EDAP TMS S.A. Company Detail
11.5.2 EDAP TMS S.A. Business Overview
11.5.3 EDAP TMS S.A. Interventional Oncology Ablation Introduction
11.5.4 EDAP TMS S.A. Revenue in Interventional Oncology Ablation Business (2019-2024)
11.5.5 EDAP TMS S.A. Recent Development
11.6 AngioDynamics
11.6.1 AngioDynamics Company Detail
11.6.2 AngioDynamics Business Overview
11.6.3 AngioDynamics Interventional Oncology Ablation Introduction
11.6.4 AngioDynamics Revenue in Interventional Oncology Ablation Business (2019-2024)
11.6.5 AngioDynamics Recent Development
11.7 CASCINATION AG
11.7.1 CASCINATION AG Company Detail
11.7.2 CASCINATION AG Business Overview
11.7.3 CASCINATION AG Interventional Oncology Ablation Introduction
11.7.4 CASCINATION AG Revenue in Interventional Oncology Ablation Business (2019-2024)
11.7.5 CASCINATION AG Recent Development
11.8 Merit Medical Systems, Inc.
11.8.1 Merit Medical Systems, Inc. Company Detail
11.8.2 Merit Medical Systems, Inc. Business Overview
11.8.3 Merit Medical Systems, Inc. Interventional Oncology Ablation Introduction
11.8.4 Merit Medical Systems, Inc. Revenue in Interventional Oncology Ablation Business (2019-2024)
11.8.5 Merit Medical Systems, Inc. Recent Development
11.9 STARmed Co.
11.9.1 STARmed Co. Company Detail
11.9.2 STARmed Co. Business Overview
11.9.3 STARmed Co. Interventional Oncology Ablation Introduction
11.9.4 STARmed Co. Revenue in Interventional Oncology Ablation Business (2019-2024)
11.9.5 STARmed Co. Recent Development
11.10 Biomedical Srl
11.10.1 Biomedical Srl Company Detail
11.10.2 Biomedical Srl Business Overview
11.10.3 Biomedical Srl Interventional Oncology Ablation Introduction
11.10.4 Biomedical Srl Revenue in Interventional Oncology Ablation Business (2019-2024)
11.10.5 Biomedical Srl Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Interventional Oncology Ablation Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Radiofrequency Ablation
Table 3. Key Players of Microwave Ablation
Table 4. Key Players of Cryoablation
Table 5. Key Players of Irreversible Electroporation Ablation
Table 6. Global Interventional Oncology Ablation Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Interventional Oncology Ablation Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Interventional Oncology Ablation Market Size by Region (2019-2024) & (US$ Million)
Table 9. Global Interventional Oncology Ablation Market Share by Region (2019-2024)
Table 10. Global Interventional Oncology Ablation Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 11. Global Interventional Oncology Ablation Market Share by Region (2025-2030)
Table 12. Interventional Oncology Ablation Market Trends
Table 13. Interventional Oncology Ablation Market Drivers
Table 14. Interventional Oncology Ablation Market Challenges
Table 15. Interventional Oncology Ablation Market Restraints
Table 16. Global Interventional Oncology Ablation Revenue by Players (2019-2024) & (US$ Million)
Table 17. Global Interventional Oncology Ablation Market Share by Players (2019-2024)
Table 18. Global Top Interventional Oncology Ablation Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Interventional Oncology Ablation as of 2023)
Table 19. Ranking of Global Top Interventional Oncology Ablation Companies by Revenue (US$ Million) in 2023
Table 20. Global 5 Largest Players Market Share by Interventional Oncology Ablation Revenue (CR5 and HHI) & (2019-2024)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Interventional Oncology Ablation Product Solution and Service
Table 23. Date of Enter into Interventional Oncology Ablation Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Interventional Oncology Ablation Market Size by Type (2019-2024) & (US$ Million)
Table 26. Global Interventional Oncology Ablation Revenue Market Share by Type (2019-2024)
Table 27. Global Interventional Oncology Ablation Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 28. Global Interventional Oncology Ablation Revenue Market Share by Type (2025-2030)
Table 29. Global Interventional Oncology Ablation Market Size by Application (2019-2024) & (US$ Million)
Table 30. Global Interventional Oncology Ablation Revenue Market Share by Application (2019-2024)
Table 31. Global Interventional Oncology Ablation Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 32. Global Interventional Oncology Ablation Revenue Market Share by Application (2025-2030)
Table 33. North America Interventional Oncology Ablation Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 34. North America Interventional Oncology Ablation Market Size by Country (2019-2024) & (US$ Million)
Table 35. North America Interventional Oncology Ablation Market Size by Country (2025-2030) & (US$ Million)
Table 36. Europe Interventional Oncology Ablation Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. Europe Interventional Oncology Ablation Market Size by Country (2019-2024) & (US$ Million)
Table 38. Europe Interventional Oncology Ablation Market Size by Country (2025-2030) & (US$ Million)
Table 39. Asia-Pacific Interventional Oncology Ablation Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 40. Asia-Pacific Interventional Oncology Ablation Market Size by Region (2019-2024) & (US$ Million)
Table 41. Asia-Pacific Interventional Oncology Ablation Market Size by Region (2025-2030) & (US$ Million)
Table 42. Latin America Interventional Oncology Ablation Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 43. Latin America Interventional Oncology Ablation Market Size by Country (2019-2024) & (US$ Million)
Table 44. Latin America Interventional Oncology Ablation Market Size by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Interventional Oncology Ablation Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 46. Middle East & Africa Interventional Oncology Ablation Market Size by Country (2019-2024) & (US$ Million)
Table 47. Middle East & Africa Interventional Oncology Ablation Market Size by Country (2025-2030) & (US$ Million)
Table 48. Boston Scientific Corporation Company Detail
Table 49. Boston Scientific Corporation Business Overview
Table 50. Boston Scientific Corporation Interventional Oncology Ablation Product
Table 51. Boston Scientific Corporation Revenue in Interventional Oncology Ablation Business (2019-2024) & (US$ Million)
Table 52. Boston Scientific Corporation Recent Development
Table 53. Johnson & Johnson Company Detail
Table 54. Johnson & Johnson Business Overview
Table 55. Johnson & Johnson Interventional Oncology Ablation Product
Table 56. Johnson & Johnson Revenue in Interventional Oncology Ablation Business (2019-2024) & (US$ Million)
Table 57. Johnson & Johnson Recent Development
Table 58. Medtronic Plc Company Detail
Table 59. Medtronic Plc Business Overview
Table 60. Medtronic Plc Interventional Oncology Ablation Product
Table 61. Medtronic Plc Revenue in Interventional Oncology Ablation Business (2019-2024) & (US$ Million)
Table 62. Medtronic Plc Recent Development
Table 63. Varian Medical Systems, Inc. Company Detail
Table 64. Varian Medical Systems, Inc. Business Overview
Table 65. Varian Medical Systems, Inc. Interventional Oncology Ablation Product
Table 66. Varian Medical Systems, Inc. Revenue in Interventional Oncology Ablation Business (2019-2024) & (US$ Million)
Table 67. Varian Medical Systems, Inc. Recent Development
Table 68. EDAP TMS S.A. Company Detail
Table 69. EDAP TMS S.A. Business Overview
Table 70. EDAP TMS S.A. Interventional Oncology Ablation Product
Table 71. EDAP TMS S.A. Revenue in Interventional Oncology Ablation Business (2019-2024) & (US$ Million)
Table 72. EDAP TMS S.A. Recent Development
Table 73. AngioDynamics Company Detail
Table 74. AngioDynamics Business Overview
Table 75. AngioDynamics Interventional Oncology Ablation Product
Table 76. AngioDynamics Revenue in Interventional Oncology Ablation Business (2019-2024) & (US$ Million)
Table 77. AngioDynamics Recent Development
Table 78. CASCINATION AG Company Detail
Table 79. CASCINATION AG Business Overview
Table 80. CASCINATION AG Interventional Oncology Ablation Product
Table 81. CASCINATION AG Revenue in Interventional Oncology Ablation Business (2019-2024) & (US$ Million)
Table 82. CASCINATION AG Recent Development
Table 83. Merit Medical Systems, Inc. Company Detail
Table 84. Merit Medical Systems, Inc. Business Overview
Table 85. Merit Medical Systems, Inc. Interventional Oncology Ablation Product
Table 86. Merit Medical Systems, Inc. Revenue in Interventional Oncology Ablation Business (2019-2024) & (US$ Million)
Table 87. Merit Medical Systems, Inc. Recent Development
Table 88. STARmed Co. Company Detail
Table 89. STARmed Co. Business Overview
Table 90. STARmed Co. Interventional Oncology Ablation Product
Table 91. STARmed Co. Revenue in Interventional Oncology Ablation Business (2019-2024) & (US$ Million)
Table 92. STARmed Co. Recent Development
Table 93. Biomedical Srl Company Detail
Table 94. Biomedical Srl Business Overview
Table 95. Biomedical Srl Interventional Oncology Ablation Product
Table 96. Biomedical Srl Revenue in Interventional Oncology Ablation Business (2019-2024) & (US$ Million)
Table 97. Biomedical Srl Recent Development
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Interventional Oncology Ablation Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Interventional Oncology Ablation Market Share by Type: 2023 VS 2030
Figure 3. Radiofrequency Ablation Features
Figure 4. Microwave Ablation Features
Figure 5. Cryoablation Features
Figure 6. Irreversible Electroporation Ablation Features
Figure 7. Global Interventional Oncology Ablation Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Interventional Oncology Ablation Market Share by Application: 2023 VS 2030
Figure 9. Hospitals & Clinics Case Studies
Figure 10. Ambulatory Surgical Centers Case Studies
Figure 11. Others Case Studies
Figure 12. Interventional Oncology Ablation Report Years Considered
Figure 13. Global Interventional Oncology Ablation Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 14. Global Interventional Oncology Ablation Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Interventional Oncology Ablation Market Share by Region: 2023 VS 2030
Figure 16. Global Interventional Oncology Ablation Market Share by Players in 2023
Figure 17. Global Top Interventional Oncology Ablation Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Interventional Oncology Ablation as of 2023)
Figure 18. The Top 10 and 5 Players Market Share by Interventional Oncology Ablation Revenue in 2023
Figure 19. North America Interventional Oncology Ablation Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. North America Interventional Oncology Ablation Market Share by Country (2019-2030)
Figure 21. United States Interventional Oncology Ablation Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Canada Interventional Oncology Ablation Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Interventional Oncology Ablation Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Interventional Oncology Ablation Market Share by Country (2019-2030)
Figure 25. Germany Interventional Oncology Ablation Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. France Interventional Oncology Ablation Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. U.K. Interventional Oncology Ablation Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Italy Interventional Oncology Ablation Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Russia Interventional Oncology Ablation Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Nordic Countries Interventional Oncology Ablation Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Interventional Oncology Ablation Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Interventional Oncology Ablation Market Share by Region (2019-2030)
Figure 33. China Interventional Oncology Ablation Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Japan Interventional Oncology Ablation Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. South Korea Interventional Oncology Ablation Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Southeast Asia Interventional Oncology Ablation Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. India Interventional Oncology Ablation Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Australia Interventional Oncology Ablation Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Interventional Oncology Ablation Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Interventional Oncology Ablation Market Share by Country (2019-2030)
Figure 41. Mexico Interventional Oncology Ablation Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Brazil Interventional Oncology Ablation Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Interventional Oncology Ablation Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Interventional Oncology Ablation Market Share by Country (2019-2030)
Figure 45. Turkey Interventional Oncology Ablation Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Saudi Arabia Interventional Oncology Ablation Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Boston Scientific Corporation Revenue Growth Rate in Interventional Oncology Ablation Business (2019-2024)
Figure 48. Johnson & Johnson Revenue Growth Rate in Interventional Oncology Ablation Business (2019-2024)
Figure 49. Medtronic Plc Revenue Growth Rate in Interventional Oncology Ablation Business (2019-2024)
Figure 50. Varian Medical Systems, Inc. Revenue Growth Rate in Interventional Oncology Ablation Business (2019-2024)
Figure 51. EDAP TMS S.A. Revenue Growth Rate in Interventional Oncology Ablation Business (2019-2024)
Figure 52. AngioDynamics Revenue Growth Rate in Interventional Oncology Ablation Business (2019-2024)
Figure 53. CASCINATION AG Revenue Growth Rate in Interventional Oncology Ablation Business (2019-2024)
Figure 54. Merit Medical Systems, Inc. Revenue Growth Rate in Interventional Oncology Ablation Business (2019-2024)
Figure 55. STARmed Co. Revenue Growth Rate in Interventional Oncology Ablation Business (2019-2024)
Figure 56. Biomedical Srl Revenue Growth Rate in Interventional Oncology Ablation Business (2019-2024)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
